Bombay High Court Overturns Hotel Licence Suspension Amid FDA Scrutiny

The bombay high court expressed its concerns regarding the maharashtra food and drug administration's (fda) recent enforcement actions against food establishmen
The Bombay High Court expressed its concerns regarding the Maharashtra Food and Drug Administration's (FDA) recent enforcement actions against food establishments, emphasizing the need for a balanced approach in the application of food safety regulations. The remarks were made during a hearing related to the Park Inn by Radisson hotel in Navi Mumbai, which contested the suspension of its food licence following an unannounced inspection by the FDA earlier this month. The court's comments highlighted the importance of public health while also advocating for a realistic perspective on enforcement practices.
A division bench, led by Acting Chief Justice Ravindra V. Ghuge, listened to arguments from the hotel's representative, advocate Mayur Khandeparkar, who criticized the FDA for not providing adequate written justification for the licence suspension. Khandeparkar pointed out that the rationale behind the suspension, which was based on the presence of insects, was overly stringent. He argued that minor infractions should not warrant such severe penalties, questioning the criteria used by the FDA in its decision-making process. The court's discussion included a light-hearted acknowledgment of the presence of insects in everyday life, with Justice Ghuge humorously referencing a fly that had appeared during the proceedings, reminding everyone that such occurrences are common in India and should be considered in the context of enforcement.





















